表紙
市場調査レポート - 224399

バイオテクノロジー市場調査レビュー

2014 Biotechnology Research Review

発行 BCC Research
出版日 ページ情報 英文 152 Pages
電子版即納可
価格
バイオテクノロジー市場調査レビュー 2014 Biotechnology Research Review
出版日: 2015年01月09日 ページ情報: 英文 152 Pages
概要

世界の遺伝子組み換えタンパク質医薬品市場額は2013年に1519億米ドルとなり、2014年には約1570億米ドルへ増加する見込みです。同市場は2014年から2019年まで7.2%のCAGRで推移し、2019年には更に2,227億米ドルへ拡大すると予測されています。世界の合成生物学市場は2012年に約21億米ドル、そして2013年に27億米ドルへ達しました。同市場は2013年から2018年の5年間に34.4%のCAGRで拡大し、2018年に118億米ドルへ成長すると予測されています。世界の癌プロファイリング技術市場は2012年に261億米ドル、2013年に約301億米ドルに達しました。同市場は2013年から2018年の5年間に12.8%のCAGRで拡大し、2018年に548億米ドルに達すると予測されています。

当レポートでは、BCC Researchが2014年に発行したバイオテクノロジー関連レポート6件のレビューを提供しています。

第1章 序文

第2章 GLOBAL MARKETS FOR BIOENGINEERED PROTEIN DRUGS (REPORT BIO009F) :「世界の遺伝子組換えタンパク質医薬品市場」

第3章 SYNTHETIC BIOLOGY: GLOBAL MARKETS (REPORT BIO066C) :「合成生物学:新たな世界的市場」

第4章 CANCER PROFILING AND PATHWAYS: TECHNOLOGIES AND GLOBAL MARKETS (REPORT BIO073B):「癌プロファイリングおよび経路:技術および世界市場」

第5章  GLOBAL MARKET FOR MICROBIOLOGY TECHNOLOGY, EQUIPMENT AND CONSUMABLES (REPORT BIO130A) :「世界の微生物学技術・装置・消耗品市場」

第6章 INDUCED PLURIPOTENT STEM CELLS: GLOBAL MARKETS (REPORT BIO135A) :「人工多能性幹細胞(iPS細胞):世界市場」

第7章 DIGITAL POLYMERASE CHAIN REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS (REPORT BIO137A) :「世界のデジタルポリメラーゼ連鎖反応(PCR)技術市場」

第8章 後注

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

REPORT HIGHLIGHTS

  • The global market for bioengineered protein drugs was valued at $151.9 billion in 2013, increasing to about $157 billion in 2014. The market is further expected to grow to about $222.7 billion in 2019, a compound annual growth rate (CAGR) of 7.2% from 2014 through 2019.
  • The global synthetic biology market reached nearly $2.1 billion in 2012 and $2.7 billion in 2013. This market is expected to grow to $11.8 billion in 2018 with a CAGR of 34.4% over the five-year period from 2013 to 2018.
  • The global market for cancer profiling technologies reached $26.1 billion in 2012 and nearly $30.1 billion in 2013. This market is expected to reach $54.8 billion in 2018, a CAGR of 12.8% over the five-year period, 2013 to 2018.

REPORT SCOPE

FOREWORD

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2014, and are an efficient way for market professionals to keep up with the general market developments of 2014.

Please note that page references in the text are to pages in the original, complete report, and do not reflect the actual page numbers in this Research Review.

This 2014 Biotechnology Research Review includes excerpts from the following reports:

  • BIO009F Global Markets for Bioengineered Protein Drugs.
  • BIO066C Synthetic Biology: Global Markets.
  • BIO073B Cancer Profiling and Pathways: Technologies and Global Markets.
  • BIO130A Global Markets for Microbiology Technology, Equipment and Consumables.
  • BIO135A Induced Pluripotent Stem Cells: Global Markets.
  • BIO137A Digital Polymerase Chain Reaction (PCR) Technology: Global Markets.

We encourage you to obtain and benefit from the full market research reports that are excerpted in this Research Review.

BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

CHAPTER 1 FOREWORD

CHAPTER 2 GLOBAL MARKETS FOR BIOENGINEERED PROTEIN DRUGS (REPORT BIO009F)

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • SUMMARY
  • TABLE 1 GLOBAL MARKET FOR BIOENGINEERED PROTEIN DRUGS BY REGION, THROUGH 2019 ($ MILLIONS)
  • FIGURE 1 GLOBAL MARKET FOR BIOENGINEERED PROTEIN DRUGS BY REGION, 2012-2019 ($ MILLIONS)
  • OVERVIEW
  • BIOSYNTHESIS OF PROTEINS
    • TRANSCRIPTION
    • TRANSLATION
    • POST-TRANSCRIPTIONAL MODIFICATIONS
    • HISTORY OF BIOENGINEERED PROTEIN DRUGS
    • TABLE 2 EVOLUTION OF BIOENGINEERED PROTEINS DRUGS
  • BIOENGINEERED PROTEIN DRUGS
  • TABLE 3 BIOENGINEERED PROTEIN DRUGS VS. CHEMICALLY SYNTHESIZED DRUGS
    • ADVANTAGES OF BIOENGINEERED PROTEIN DRUGS
    • MANUFACTURING TECHNOLOGY
      • Fractionation or Cohn Process
      • TABLE 4 PROTEIN DRUGS MADE BY FRACTIONATION
      • Microbial Cell Fermentation and Bioreactors
      • TABLE 5 THERAPEUTIC DRUGS PRODUCED BY MICROBIAL FERMENTATION
      • Genetic Engineering
      • Genetically Modified Organisms
      • Pharming
      • TABLE 6 PROTEIN DRUGS PRODUCED BY TRANSGENIC ANIMALS, PLANTS AND MICROORGANISMS
      • Mammalian Cell Culture
      • TABLE 7 PROTEIN DRUGS MADE BY CELL CULTURE
      • Cell-Free Protein Synthesis Systems
    • ADMINISTRATION TECHNOLOGIES OF BIOENGINEERED PROTEIN DRUGS
      • Traditional Methods of Drug Delivery
        • Oral
        • Topical
        • Transmucosal
        • Inhalation
        • Parenteral
        • TABLE 8 ROUTES OF DRUG DELIVERY
      • Limitations Encountered by Traditional Drug Delivery
      • Current Research and Novel Approaches
        • Targeted Drug Delivery Carriers
        • Micelles
        • Liposomes
        • Microspheres
        • Nanoparticles
        • Microemulsions
        • Hydrogels
        • Thin-film Drug Delivery
        • Prodrug
    • MOLECULAR CLASSIFICATION OF PROTEIN DRUGS
      • Monoclonal Antibodies
      • Cytokines
        • Interferons
        • Interleukins
        • Colony Stimulating Factors
      • Peptide Hormones
        • Follicle Stimulating Hormones and Luteinizing Hormones
        • Growth Hormones
        • Erythropoietin
        • Insulin
      • Vaccines
        • Live Attenuated Vaccines
        • Inactivated/Killed Vaccines
        • Toxoid
        • Subunit/Conjugate
      • Therapeutic Enzymes
        • Digestive Enzymes
        • Metabolic Enzymes
        • Other Enzymes
      • Peptide Antibiotics
      • Blood Products
        • Alpha 1-Protease Inhibitor
        • Antihemophilic Factor
        • Antithrombin
        • C1 Esterase Inhibitor
        • Coagulation Factors
        • Immune Globulins
        • Protein C
        • Thrombin

CHAPTER 3 SYNTHETIC BIOLOGY: GLOBAL MARKETS (REPORT BIO066C)

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • CONTRIBUTION OF THE STUDY AND FOR WHOM
  • SCOPE AND FORMAT
  • TABLE 9 SCOPE OF REPORT
  • METHODOLOGY
  • INFORMATION SOURCES
  • RELATED BCC RESEARCH REPORTS
  • SUMMARY
  • TABLE 10 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
  • FIGURE 2 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCT TYPE, 2012-2018 ($ MILLIONS)
  • OVERVIEW
  • TABLE 11 SCOPE OF THIS REPORT
  • FIGURE 3 SYNTHETIC BIOLOGY VALUE-ADDED CHAIN
  • WHAT IS SYNTHETIC BIOLOGY?
  • DEVELOPMENT STAGE OF SYNTHETIC BIOLOGY
  • FIGURE 4 FROM THE NATURAL TO THE ARTIFICIAL
  • TABLE 12 SYNTHETIC BIOLOGY PARADIGM
  • FORCES DRIVING SYNTHETIC BIOLOGY MARKET GROWTH
  • TABLE 13 SYNTHETIC BIOLOGY GROWTH: DRIVING FORCES
  • GLOBAL MARKETS FOR SYNTHETIC BIOLOGY PRODUCTS
  • TABLE 14 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END-USER INDUSTRY, THROUGH 2018 ($ MILLIONS)
  • LIFE CYCLE STATUS OF PRODUCTS AND TECHNOLOGIES
  • TABLE 15 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
  • SYNTHETIC BIOLOGY INDUSTRY
  • TABLE 16 SYNTHETIC BIOLOGY COMPETITORS BY MARKET FOCUS
  • SYNTHETIC BIOLOGY TECHNOLOGIES
    • SYNTHETIC BIOLOGY DEFINED
    • TABLE 17 SYNTHETIC BIOLOGY DEFINITIONS
    • HISTORY OF SYNTHETIC BIOLOGY
    • TABLE 18 SYNTHETIC BIOLOGY HISTORY
    • PARADIGM SHIFT IN BIOLOGY
    • TABLE 19 PARADIGM SHIFT CAUSED BY SYNTHETIC BIOLOGY
    • TABLE 20 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARED
    • FIGURE 5 SCALE OF SYNTHETIC BIOLOGY
  • SYNTHETIC BIOLOGY TECHNOLOGY OVERVIEW
  • TABLE 21 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGY
  • ENABLING TECHNOLOGIES
  • TABLE 22 IMPORTANCE OF ENABLING TECHNOLOGIES
    • DNA SYNTHESIS AND SEQUENCING COST TRENDS
    • TABLE 23 COSTS TO SEQUENCE AND SYNTHESIZE A HUMAN GENOME, 2001-2014
    • DNA SYNTHESIS TECHNOLOGIES
    • FIGURE 6 SCHEMATIC OF GENE SYNTHESIS TECHNOLOGIES
    • TABLE 24 COMPARISONS OF GENE SYNTHESIS TECHNOLOGIES
      • PCR-Based Approaches
      • Solid-Phase Approaches
    • MICROFLUIDIC TECHNOLOGIES
    • TABLE 25 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETIC BIOLOGY
    • DNA Microarrays: Oligos Synthesis
    • TABLE 26 MICROARRAY TYPES
    • TABLE 27 DNA MICROARRAY PLATFORM FEATURES

CHAPTER 4 CANCER PROFILING AND PATHWAYS: TECHNOLOGIES AND GLOBAL MARKETS (REPORT BIO073B)

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • INTENDED AUDIENCE
  • METHODOLOGY
  • INFORMATION SOURCES
  • ABOUT THE AUTHOR
  • RELATED BCC RESEARCH REPORTS
  • SUMMARY OF CANCER PROFILING AND PATHWAYS
  • TABLE 28 MARKET FOR CANCER PROFILING TECHNOLOGIES, THROUGH 2018 ($ MILLIONS)
  • FIGURE 7 MARKET FOR CANCER PROFILING TECHNOLOGIES, 2012-2018 ($ MILLIONS)
  • CANCER PROFILING OVERVIEW
  • BIOMARKERS
  • GUIDELINES
    • SCREENING TESTS
    • EARLY DETECTION AND DIAGNOSIS OF CANCER
    • PATHWAY PROFILING
    • LINKING CANCER DISEASE THROUGH PATHWAY PROFILING
    • MOLECULAR PROFILING
    • HISTORICAL FACTS
    • MOLECULAR PROFILES
    • ONCOTYPE DX
  • CANCER PROFILING
    • CHALLENGES
    • PRIMARY OBJECTIVES OF THE MINDACT TRIAL
      • Lung Cancer
      • Challenges
  • CLINICAL UTILITY OF MOLECULAR PROFILING
    • CARIS LIFE SCIENCES
    • Head and Neck Cancer Data
    • Pathological Classification
  • MOLECULAR PROFILING APPROACHES
  • TABLE 29 DIFFERENT TOOLS FOR MOLECULAR PROFILING OF CANCER
  • CANCER PROFILING: FUTURE GOALS

CHAPTER 5 GLOBAL MARKET FOR MICROBIOLOGY TECHNOLOGY, EQUIPMENT AND CONSUMABLES (REPORT BIO130A)

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • INTENDED AUDIENCE
  • INFORMATION SOURCES
  • ANALYST CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • SUMMARY
  • TABLE 30 GLOBAL CONSUMABLE, EQUIPMENT AND TECHNOLOGY MARKET BY MICROBIOLOGY INDUSTRY BY SECTOR, THROUGH 2018 ($ MILLIONS) 89
  • FIGURE 8 GLOBAL CONSUMABLE, EQUIPMENT AND TECHNOLOGY MARKET BY MICROBIOLOGY INDUSTRY BY SECTOR, 2011-2018 ($ MILLIONS)
  • RISE OF INDUSTRIAL MICROBIOLOGY
  • FASTER IS BETTER 9
  • MOLECULAR TECHNIQUES THROUGHOUT THE INDUSTRY
  • BIOFUEL POWER
  • MICROBES AS A BUSINESS
  • MICROBIOLOGY TECHNOLOGY USES
  • MICROBIOLOGY OVERVIEW
  • SECTORS
    • ACADEMIA
    • GOVERNMENT
    • PUBLIC HEALTH
      • Regulatory
        • Food, Drugs and Healthcare Products
    • INDUSTRY
      • Clinical
      • Pharmaceutical
      • Environmental
      • Manufacturing
      • Energy
      • Food
  • USES
    • CLINICAL
      • Technology
      • Equipment
      • Consumables
    • ENVIRONMENTAL MICROBIOLOGY
      • Technology
      • Equipment
      • Consumables
    • EPIDEMIOLOGY
      • Technology
      • Equipment
      • Consumables
    • PRODUCT MANUFACTURING
      • Food
      • Technology
      • Equipment
      • Consumables
    • ENERGY
      • Technology
      • Equipment
      • Consumables
    • INDUSTRIAL MICROBIOLOGY
      • Technology
      • Equipment
      • Consumables

CHAPTER 6 INDUCED PLURIPOTENT STEM CELLS: GLOBAL MARKETS (REPORT BIO135A)

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • INTENDED AUDIENCE
  • SCOPE OF REPORT
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYST CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • MARKET SUMMARY
  • KEY DRIVERS FOR MARKET GROWTH
  • TABLE 31 GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
  • FIGURE 9 GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET BY REGION, 2012-2018 ($ MILLIONS)
  • INDUCED PLURIPOTENT STEM CELL OVERVIEW
  • HISTORY AND CURRENT STATE
  • EVOLUTION OF INDUCED PLURIPOTENT STEM CELL RESEARCH
  • INDUCED PLURIPOTENT STEM CELL ADVANTAGES AND DISADVANTAGES
    • ADVANTAGES
    • DISADVANTAGES
  • TECHNOLOGY OVERVIEW
    • INDUCED PLURIPOTENT STEM CELL GENERATION
      • Retrovirus and Lentivirus
      • Adenovirus
      • Sendai Virus
      • Episomal Plasmids
      • PiggyBac
      • Minicircle Vectors
      • Synthetic mRNA
      • Protein
      • Small-Molecular Chemicals
    • INDUCED PLURIPOTENT STEM CELL DIFFERENTIATION
      • Cardiomyocytes
      • Hepatocytes
      • Neurons
      • Endothelia Cells
  • INDUCED PLURIPOTENT STEM CELL APPLICATIONS
  • ACADEMIC RESEARCH
  • PHARMACO-TOXICOLOGICAL SCREENING
  • DRUG DISCOVERY AND DEVELOPMENT
  • DISEASE MODELING
  • TISSUE ENGINEERING
  • CELL THERAPY

CHAPTER 7 DIGITAL POLYMERASE CHAIN REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS (REPORT BIO137A)

  • STUDY OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • INTENDED AUDIENCE
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • INDUSTRY TRENDS
  • EXPLOSIVE GROWTH IN DIGITAL PCR
  • KEY PLAYERS IN THE EQUIPMENT AND ASSAY SEGMENTS
  • END OF THE LDT
  • TECHNIQUE MATTERS
  • CURE FOR CANCER AND AIDS
  • A CHEAPER WAY FOR ACADEMIA
  • A SOLUTION TO CHALLENGING PCR PROBLEMS
  • STEEP LEARNING CURVE
  • TABLE 32 GLOBAL MARKET FOR DIGITAL PCR TECHNOLOGY BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • FIGURE 10 GLOBAL MARKET FOR DIGITAL PCR TECHNOLOGY BY SEGMENT, 2011-2018 ($ MILLIONS)
  • OVERVIEW OF PCR TECHNOLOGY
    • EVOLUTION OF PCR TECHNOLOGY AND ITS IMPACT ON THE HEALTHCARE INDUSTRY
    • FIGURE 11 IMPACT OF PCR TECHNOLOGY ON THE HEALTHCARE ENVIRONMENT
    • TRENDS IN DEVICE DESIGN
    • TRADITIONAL PCR VS. REAL-TIME PCR
    • RAPID GROWTH IN THE MOLECULAR DIAGNOSTIC INDUSTRY
    • PRODUCT INNOVATIONS INCREASE TECHNOLOGY ADOPTION AND APPLICATION AREAS
    • WIDE RANGE OF APPLICATIONS
    • MARKET CHALLENGES
      • Lack of Awareness
      • Requirement for Skilled Labor
      • High Cost of Real-time PCR Instruments
      • INSTRUMENT SELECTION CRITERIA
      • TABLE 33 COMPARISONS OF DIGITAL PCR TECHNOLOGIES
  • HISTORY OF DIGITAL PCR TECHNOLOGY
  • HOW THE TECHNOLOGY WORKS
  • VARIATIONS ON THE TECHNOLOGY
    • MICROFLUIDIC DIGITAL PCR
    • DROPLET DIGITAL PCR
    • BEAM DIGITAL PCR
  • SECTORS
    • PHARMACEUTICAL/BIOTECH AND CLINICAL DEVELOPMENT
    • CLINICAL DIAGNOSTICS
    • ACADEMIA
    • OTHER SECTORS
  • USES
    • ONCOLOGY
    • HIV
    • NEXT-GENERATION SEQUENCING
    • INFECTIOUS DISEASE
    • NON-INVASIVE DIAGNOSTICS
    • SNP DETECTION
    • EMERGING USES
    • SUMMARY

CHAPTER 8 ENDNOTES

LIST OF TABLES

  • TABLE 1 GLOBAL MARKET FOR BIOENGINEERED PROTEIN DRUGS BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 2 EVOLUTION OF BIOENGINEERED PROTEINS DRUGS
  • TABLE 3 BIOENGINEERED PROTEIN DRUGS VS. CHEMICALLY SYNTHESIZED DRUGS
  • TABLE 4 PROTEIN DRUGS MADE BY FRACTIONATION
  • TABLE 5 THERAPEUTIC DRUGS PRODUCED BY MICROBIAL FERMENTATION
  • TABLE 6 PROTEIN DRUGS PRODUCED BY TRANSGENIC ANIMALS, PLANTS AND MICROORGANISMS
  • TABLE 7 PROTEIN DRUGS MADE BY CELL CULTURE
  • TABLE 8 ROUTES OF DRUG DELIVERY
  • TABLE 9 SCOPE OF REPORT
  • TABLE 10 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCT TYPE, THROUGH 2018 ($ MILLIONS)
  • TABLE 11 SCOPE OF THIS REPORT
  • TABLE 12 SYNTHETIC BIOLOGY PARADIGM
  • TABLE 13 SYNTHETIC BIOLOGY GROWTH: DRIVING FORCES
  • TABLE 14 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END-USER INDUSTRY, THROUGH 2018 ($ MILLIONS)
  • TABLE 15 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
  • TABLE 16 SYNTHETIC BIOLOGY COMPETITORS BY MARKET FOCUS
  • TABLE 17 SYNTHETIC BIOLOGY DEFINITIONS
  • TABLE 18 SYNTHETIC BIOLOGY HISTORY
  • TABLE 19 PARADIGM SHIFT CAUSED BY SYNTHETIC BIOLOGY
  • TABLE 20 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARED
  • TABLE 21 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGY
  • TABLE 22 IMPORTANCE OF ENABLING TECHNOLOGIES
  • TABLE 23 COSTS TO SEQUENCE AND SYNTHESIZE A HUMAN GENOME, 2001-2014
  • TABLE 24 COMPARISONS OF GENE SYNTHESIS TECHNOLOGIES
  • TABLE 25 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETIC BIOLOGY
  • TABLE 26 MICROARRAY TYPES
  • TABLE 27 DNA MICROARRAY PLATFORM FEATURES
  • TABLE 28 MARKET FOR CANCER PROFILING TECHNOLOGIES, THROUGH 2018 ($ MILLIONS)
  • TABLE 29 DIFFERENT TOOLS FOR MOLECULAR PROFILING OF CANCER
  • TABLE 30 GLOBAL CONSUMABLE, EQUIPMENT AND TECHNOLOGY MARKET BY MICROBIOLOGY INDUSTRY BY SECTOR, THROUGH 2018 ($ MILLIONS)
  • TABLE 31 GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
  • TABLE 32 GLOBAL MARKET FOR DIGITAL PCR TECHNOLOGY BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • TABLE 33 COMPARISONS OF DIGITAL PCR TECHNOLOGIES

LIST OF FIGURES

  • FIGURE 1 GLOBAL MARKET FOR BIOENGINEERED PROTEIN DRUGS BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 2 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCT TYPE, 2012-2018 ($ MILLIONS)
  • FIGURE 3 SYNTHETIC BIOLOGY VALUE-ADDED CHAIN
  • FIGURE 4 FROM THE NATURAL TO THE ARTIFICIAL
  • FIGURE 5 SCALE OF SYNTHETIC BIOLOGY
  • FIGURE 6 SCHEMATIC OF GENE SYNTHESIS TECHNOLOGIES
  • FIGURE 7 MARKET FOR CANCER PROFILING TECHNOLOGIES, 2012-2018 ($ MILLIONS)
  • FIGURE 8 GLOBAL CONSUMABLE, EQUIPMENT AND TECHNOLOGY MARKET BYMICROBIOLOGY INDUSTRY BY SECTOR, 2011-2018 ($ MILLIONS)
  • FIGURE 9 GLOBAL INDUCED PLURIPOTENT STEM CELL MARKET BY REGION, 2012-2018 ($ MILLIONS)
  • FIGURE 10 GLOBAL MARKET FOR DIGITAL PCR TECHNOLOGY BY SEGMENT, 2011-2018 ($ MILLIONS)
  • FIGURE 11 IMPACT OF PCR TECHNOLOGY ON THE HEALTHCARE ENVIRONMENT
Back to Top